Alzheimer's Lantern

Free guides › Understanding Alzheimer's

New Alzheimer's treatments in plain English

Two newer medicines can slow Alzheimer's in its early stage. They aren't a cure and aren't right for everyone. Here's what they do, who they're for, and what to ask.

We are not medical professionals. This guide is general information, not medical advice. Please talk to a doctor about your own situation. In an emergency, call 911. Read our full disclaimer.

Two kinds of Alzheimer's medicines

1. Medicines that ease symptoms. These have been used for many years. They don't change the course of the disease, but they can help memory, thinking, or behavior for a while in some people.

  • Donepezil, rivastigmine, and galantamine are used in mild to moderate (and sometimes severe) stages.
  • Memantine is used in moderate to severe stages, sometimes together with donepezil.
  • Common side effects include upset stomach, loss of appetite, dizziness, and sleep changes.

2. Medicines that slow the disease. These are newer and work in a different way. They target amyloid, the sticky protein that builds up in the brains of people with Alzheimer's.

The newer medicines

  • Lecanemab (brand name Leqembi), approved by the FDA in 2023
  • Donanemab (brand name Kisunla), approved by the FDA in 2024

In large studies, both modestly slowed the decline of memory and thinking over about 18 months in people with early Alzheimer's, compared with people who got a placebo. They do not stop the disease or bring back lost memory.

Who they're for

  • People with mild cognitive impairment or mild dementia caused by Alzheimer's
  • Amyloid must be confirmed with a PET scan or a spinal fluid test
  • They're not for people in the moderate or late stage

How they're given

  • Usually by IV infusion at a clinic, every 2 weeks (lecanemab) or every 4 weeks (donanemab)
  • Regular MRI brain scans are needed to check for side effects

Side effects to know about

The main risk is called ARIA: swelling or small bleeds in the brain. Most of the time it causes no symptoms and goes away, but it can be serious, and rarely life-threatening.

  • People who carry two copies of a gene called APOE-e4 have a higher risk. Doctors may suggest a genetic test first.
  • People who take blood thinners may face extra risk.
  • Call the doctor right away about new headache, confusion, dizziness, vision changes, or nausea.

Questions to ask the doctor

  • Is this treatment an option for us? Why or why not?
  • What tests do we need first?
  • How much benefit might we expect, and how will we know if it's working?
  • What are the risks for us, given our genes and other medicines?
  • How often are infusions and MRIs, and where?
  • What will Medicare or our insurance cover, and what will we pay?

Other ways to help

Whatever treatment you choose, everyday things still matter a lot: exercise, sleep, social time, treating hearing loss, controlling blood pressure, and staying engaged. Clinical trials are also testing many new treatments. Ask the doctor, or search ClinicalTrials.gov.

Sources

Want calm, practical help like this every week? Get the Friday letter. It's free.